170 related articles for article (PubMed ID: 32947020)
21. Perlecan, the "jack of all trades" proteoglycan of cartilaginous weight-bearing connective tissues.
Melrose J; Hayes AJ; Whitelock JM; Little CB
Bioessays; 2008 May; 30(5):457-69. PubMed ID: 18404701
[TBL] [Abstract][Full Text] [Related]
22. Perlecan, the multidomain heparan sulfate proteoglycan of basement membranes, is also a prominent component of the cartilaginous primordia in the developing human fetal spine.
Melrose J; Smith S; Ghosh P; Whitelock J
J Histochem Cytochem; 2003 Oct; 51(10):1331-41. PubMed ID: 14500701
[TBL] [Abstract][Full Text] [Related]
23. Integrin alpha2beta1 is the required receptor for endorepellin angiostatic activity.
Woodall BP; Nyström A; Iozzo RA; Eble JA; Niland S; Krieg T; Eckes B; Pozzi A; Iozzo RV
J Biol Chem; 2008 Jan; 283(4):2335-43. PubMed ID: 18024432
[TBL] [Abstract][Full Text] [Related]
24. Perlecan regulates developmental angiogenesis by modulating the VEGF-VEGFR2 axis.
Zoeller JJ; Whitelock JM; Iozzo RV
Matrix Biol; 2009 Jun; 28(5):284-91. PubMed ID: 19422911
[TBL] [Abstract][Full Text] [Related]
25. Endorepellin, the C-terminal angiostatic module of perlecan, enhances collagen-platelet responses via the alpha2beta1-integrin receptor.
Bix G; Iozzo RA; Woodall B; Burrows M; McQuillan A; Campbell S; Fields GB; Iozzo RV
Blood; 2007 May; 109(9):3745-8. PubMed ID: 17197432
[TBL] [Abstract][Full Text] [Related]
26. Elevated hypertrophy, growth plate maturation, glycosaminoglycan deposition, and exostosis formation in the
Shu CC; Smith SM; Little CB; Melrose J
Biochem J; 2019 Jan; 476(2):225-243. PubMed ID: 30563944
[TBL] [Abstract][Full Text] [Related]
27. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.
Whitelock JM; Murdoch AD; Iozzo RV; Underwood PA
J Biol Chem; 1996 Apr; 271(17):10079-86. PubMed ID: 8626565
[TBL] [Abstract][Full Text] [Related]
28. Single molecule force measurements of perlecan/HSPG2: A key component of the osteocyte pericellular matrix.
Wijeratne SS; Martinez JR; Grindel BJ; Frey EW; Li J; Wang L; Farach-Carson MC; Kiang CH
Matrix Biol; 2016 Mar; 50():27-38. PubMed ID: 26546708
[TBL] [Abstract][Full Text] [Related]
29. Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.
Gotha L; Lim SY; Osherov AB; Wolff R; Qiang B; Erlich I; Nili N; Pillarisetti S; Chang YT; Tran PK; Tryggvason K; Hedin U; Tran-Lundmark K; Advani SL; Gilbert RE; Strauss BH
Am J Physiol Heart Circ Physiol; 2014 Aug; 307(3):H337-45. PubMed ID: 24858854
[TBL] [Abstract][Full Text] [Related]
30. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan.
Hayashi K; Madri JA; Yurchenco PD
J Cell Biol; 1992 Nov; 119(4):945-59. PubMed ID: 1385448
[TBL] [Abstract][Full Text] [Related]
31. Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.
Tang F; Lord MS; Stallcup WB; Whitelock JM
J Biochem; 2018 May; 163(5):399-412. PubMed ID: 29462330
[TBL] [Abstract][Full Text] [Related]
32. A novel peptide sequence in perlecan domain IV supports cell adhesion, spreading and FAK activation.
Farach-Carson MC; Brown AJ; Lynam M; Safran JB; Carson DD
Matrix Biol; 2008 Mar; 27(2):150-60. PubMed ID: 17997086
[TBL] [Abstract][Full Text] [Related]
33. Perlecan protein core interacts with extracellular matrix protein 1 (ECM1), a glycoprotein involved in bone formation and angiogenesis.
Mongiat M; Fu J; Oldershaw R; Greenhalgh R; Gown AM; Iozzo RV
J Biol Chem; 2003 May; 278(19):17491-9. PubMed ID: 12604605
[TBL] [Abstract][Full Text] [Related]
34. What Are the Potential Roles of Nuclear Perlecan and Other Heparan Sulphate Proteoglycans in the Normal and Malignant Phenotype.
Hayes AJ; Melrose J
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922532
[TBL] [Abstract][Full Text] [Related]
35. Perlecan inhibits smooth muscle cell adhesion to fibronectin: role of heparan sulfate.
Lundmark K; Tran PK; Kinsella MG; Clowes AW; Wight TN; Hedin U
J Cell Physiol; 2001 Jul; 188(1):67-74. PubMed ID: 11382923
[TBL] [Abstract][Full Text] [Related]
36. Perlecan domain V inhibits amyloid-β induced brain endothelial cell toxicity and restores angiogenic function.
Parham C; Auckland L; Rachwal J; Clarke D; Bix G
J Alzheimers Dis; 2014; 38(2):415-23. PubMed ID: 23979025
[TBL] [Abstract][Full Text] [Related]
37. Perlecan, a candidate gene for the CAPB locus, regulates prostate cancer cell growth via the Sonic Hedgehog pathway.
Datta MW; Hernandez AM; Schlicht MJ; Kahler AJ; DeGueme AM; Dhir R; Shah RB; Farach-Carson C; Barrett A; Datta S
Mol Cancer; 2006 Mar; 5():9. PubMed ID: 16507112
[TBL] [Abstract][Full Text] [Related]
38. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
[TBL] [Abstract][Full Text] [Related]
39. Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system.
Wang B; Lai X; Price C; Thompson WR; Li W; Quabili TR; Tseng WJ; Liu XS; Zhang H; Pan J; Kirn-Safran CB; Farach-Carson MC; Wang L
J Bone Miner Res; 2014 Apr; 29(4):878-91. PubMed ID: 24115222
[TBL] [Abstract][Full Text] [Related]
40. Flipping the Molecular Switch: Influence of Perlecan and Its Modifiers in the Tumor Microenvironment.
Cruz LA; Tellman TV; Farach-Carson MC
Adv Exp Med Biol; 2020; 1245():133-146. PubMed ID: 32266656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
